A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
Article first published online: 14 NOV 2005
Copyright © 2005 Wiley-Liss, Inc.
International Journal of Cancer
Volume 118, Issue 4, pages 791–796, 15 February 2006
How to Cite
Davies, P., Arbyn, M., Dillner, J., Kitchener, H. C., Meijer, C. J.L.M., Ronco, G. and Hakama, M. (2006), A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int. J. Cancer, 118: 791–796. doi: 10.1002/ijc.21611
- Issue published online: 13 DEC 2005
- Article first published online: 14 NOV 2005
- Manuscript Accepted: 9 SEP 2005
- Manuscript Received: 4 JUL 2005
- human papillomavirus;
- cervical cancer;
- randomized controlled trial;
Cervical cancer remains a significant public health concern, both at a global and a European level. A number of new technologies such as diagnostic tests for human papillomavirus (HPV) have a potential to assist with the reduction of this disease. However, both the efficacy and the cost-effectiveness of these new technologies must be established in properly designed trials before they can be implemented within national public health programs. Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test. © 2005 Wiley-Liss, Inc.